Synovics Pharmaceuticals, Inc. (SYVC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Oct 13, 2025
Synovics Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | 1999 - 2003 |
|---|---|---|---|---|---|---|---|
Period Ending | Jul '09 Jul 31, 2009 | Oct '08 Oct 31, 2008 | Oct '07 Oct 31, 2007 | Oct '06 Oct 31, 2006 | Oct '05 Oct 31, 2005 | Oct '04 Oct 31, 2004 | 1999 - 2003 |
| 19.09 | 25.96 | 23.47 | 10.52 | 0.01 | 0.1 | Upgrade | |
Revenue Growth (YoY) | -18.48% | 10.63% | 123.14% | 128274.00% | -91.71% | 208.86% | Upgrade |
Cost of Revenue | 14.63 | 16.99 | 16.84 | 8.16 | 0.05 | 0.02 | Upgrade |
Gross Profit | 4.47 | 8.97 | 6.63 | 2.36 | -0.04 | 0.08 | Upgrade |
Selling, General & Admin | 7.62 | 10.28 | 15.6 | 4.78 | 0.35 | 0.87 | Upgrade |
Research & Development | 1.17 | 1.18 | 1.29 | 1.2 | 1.52 | 0 | Upgrade |
Operating Expenses | 8.78 | 11.45 | 16.89 | 5.98 | 1.87 | 0.87 | Upgrade |
Operating Income | -4.32 | -2.48 | -10.26 | -3.62 | -1.91 | -0.79 | Upgrade |
Interest Expense | -0.71 | -4.17 | -6.4 | -3.91 | -0.79 | -0 | Upgrade |
Other Non Operating Income (Expenses) | 0 | - | 0.01 | - | 0.01 | -0 | Upgrade |
EBT Excluding Unusual Items | -5.02 | -6.65 | -16.65 | -7.53 | -2.69 | -0.79 | Upgrade |
Impairment of Goodwill | -0.66 | -0.66 | -4.01 | - | - | - | Upgrade |
Gain (Loss) on Sale of Assets | -0.02 | -0.02 | -0.2 | - | - | - | Upgrade |
Other Unusual Items | - | 3.33 | - | - | - | - | Upgrade |
Pretax Income | -5.04 | -4.01 | -20.86 | -7.53 | -2.69 | -0.79 | Upgrade |
Earnings From Continuing Operations | -5.04 | -4.01 | -20.86 | -7.53 | -2.69 | -0.79 | Upgrade |
Earnings From Discontinued Operations | - | - | - | -1.04 | -0.22 | -0.33 | Upgrade |
Net Income | -5.04 | -4.01 | -20.86 | -8.57 | -2.91 | -1.12 | Upgrade |
Net Income to Common | -5.04 | -4.01 | -20.86 | -8.57 | -2.91 | -1.12 | Upgrade |
Shares Outstanding (Basic) | 28 | 24 | 19 | 26 | 20 | 8 | Upgrade |
Shares Outstanding (Diluted) | 28 | 24 | 19 | 26 | 20 | 8 | Upgrade |
Shares Change (YoY) | 84.15% | 23.47% | -26.78% | 29.61% | 156.30% | 80.13% | Upgrade |
EPS (Basic) | -0.18 | -0.17 | -1.09 | -0.33 | -0.14 | -0.14 | Upgrade |
EPS (Diluted) | -0.18 | -0.17 | -1.09 | -0.33 | -0.14 | -0.14 | Upgrade |
Free Cash Flow | 1.77 | 3.15 | -3.12 | -5.61 | -2.5 | -0.64 | Upgrade |
Free Cash Flow Per Share | 0.06 | 0.13 | -0.16 | -0.22 | -0.12 | -0.08 | Upgrade |
Gross Margin | 23.39% | 34.56% | 28.25% | 22.42% | - | 81.50% | Upgrade |
Operating Margin | -22.62% | -9.57% | -43.74% | -34.41% | -23334.53% | -796.23% | Upgrade |
Profit Margin | -26.42% | -15.43% | -88.88% | -81.50% | -35537.84% | -1138.37% | Upgrade |
Free Cash Flow Margin | 9.29% | 12.15% | -13.29% | -53.38% | -30467.47% | -651.93% | Upgrade |
EBITDA | -3.64 | -1.87 | -9.67 | -3.5 | -1.88 | -0.76 | Upgrade |
EBITDA Margin | -19.09% | -7.21% | -41.20% | -33.25% | - | - | Upgrade |
D&A For EBITDA | 0.67 | 0.61 | 0.6 | 0.12 | 0.03 | 0.03 | Upgrade |
EBIT | -4.32 | -2.48 | -10.26 | -3.62 | -1.91 | -0.79 | Upgrade |
EBIT Margin | -22.62% | -9.57% | -43.74% | -34.41% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.